Liver Disease
Conference Coverage
Emerging Evidence Supports Dietary Management of MASLD Through Gut-Liver Axis
Dietary fats were most consistently associated with inflammatory markers, with inflammation being positively associated with saturated fats and...
Conference Coverage
Healthy Sleep Linked to Lower Odds for Digestive Diseases
Those with healthy sleep had more than a quarter lower risk of developing digestive disease, study finds.
Conference Coverage
In IBD Patients, Statin Use Associated with Lower Risk of Developing PSC
Statin use was associated with an 86% risk reduction, and only .09% of IBD patients who took statins developed PSC.
From the AGA Journals
High-Alcohol Intake in MASLD Increases Risk of Cirrhosis
In a significant study observation, fewer than 5% of US veterans with high-risk use received behavioral or pharmacologic therapy.
Latest News
A Single Meatless Meal Can Benefit Patients With Cirrhosis
Protein-heavy meals can increase ammonia, increasing risk for patients with cirrhosis, study finds.
From the Journals
Probiotics Emerge as Promising Intervention in Cirrhosis
“The study shows that probiotics can improve some disease markers in cirrhosis,” said Dr. Phillipp Hartmann.
The New Gastroenterologist
May 2024 – ICYMI
Perspectives
Artificial Intelligence in GI and Hepatology
As the global discussion on AI has shown, there are real challenges with adoption, including issues with accuracy, reliability, and privacy.
Latest News
Metabolic Dysfunction–Associated Steatotic Liver Disease Plus HIV Ups Risk for CVD but Not Liver Disease
Compared with MASLD without HIV, the overall 5-year survival was significantly lower in MASLD with HIV, likely becuase of comorbidities.
From the AGA Journals
Real-World HDV Study Characterizes Responses to Bulevirtide
The findings suggest that longer follow-up is needed to determine optimal treatment duration for bulevirtide monotherapy.